Nanotechnology in Cancer: Engineering for Oncology
|Date & Time||September 12-14, 2019|
|Address||Storey's Way CB3 0DS
Churchill College, University of Cambridge
This new conference bridges nanotechnology with clinical and pre-clinical cancer research, and will highlight recent applications in patient care. It will provide an overview of the latest developments in the field of cancer-related nanotechnologies. There will be many opportunities to present work, with lively poster sessions and eight proffered papers selected from submitted abstracts.
Nanotechnology offers exciting opportunities in the fight against cancer. New technological breakthroughs have enabled innovative therapeutic applications of nanoparticles and have facilitated diagnostics at the nanoscale. As examples, the delivery of RNA with nanoparticles (in the product patisiran), has been approved by EMA/FDA in 2018, while the first liquid biopsy for prostate cancer based on exosome analysis was launched in 2016.
Topics to be covered:
- Nanomedicine for effective delivery of siRNA, mRNA, CRISPR-Cas9, and others;
- Exosomes in cancer theranostics;
- Detection and combined treatments of early-stage disease;
- Nanomedicine and cancer immunotherapy.
Scientific Programme Committee:
- Caroline Dive, CRUK Manchester Institute, UK
- Kostas Kostarelos (Chair), University of Manchester, UK
- Raymond Schiffelers, UMC Utrecht, Netherlands
- Claire Wilhelm, Paris Diderot University, France
COME AND MEET US IN PERSON!
Martin de Kort, Scientific Programme Manager, will attend this conference. We are looking forward to meeting you at Cambridge.